ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Considerations for conducting developmental neuroimaging research on mental health topics.
Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Practical considerations for dense longitudinal neuroimaging: Ten simple rules for frequent scanning over short time periods.Developmental cognitive neuroscience · 2026Article
- Trajectories of mental health and mental illness: where we are now and where we go next.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This commentary serves as a primer for trainees and experienced researchers who are new to neuroimaging of pediatric clinical populations. Non-invasive neuroimaging is now possible across the entire lifespan and encompasses a wide variety of tools and techniques. Developmental neuroimaging has been a fertile research ground for advancing new techniques and innovating approaches for group comparisons, including of those with psychopathology. However, developmental neuroimaging is hard to do well, and three reasons why are discussed: 1) Biology is on the move in development, and neuroimaging techniques are challenged by the high variability over age and across individuals; 2) Many cognitive constructs of interest in both behavior and psychopathology are interrelated and fuzzy, causing difficulty in interpretation of neuroimaging results; and 3) neuroimaging of pediatric populations, especially clinical samples, requires several special considerations in design and execution to be successful. Through discussion of these points, and note of some creative solutions in recent work, we hope to encourage more to research basic open questions in the field, and to inspire adherence towards rigorous and reproducible science.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.